摘要:
The invention relates to modulating the SIRPα-CD47 interaction in order to treat hematological cancer and compounds therefor. In some embodiments, there is provided methods and uses of SIRPα polypeptides, fragments and fusion proteins for treating hematological cancer, preferably human acute myeloid leukemia.
摘要:
A compound for use in a method for treating cancer cells or tumours that are CD47+, the compound comprising a polypeptide capable of modulating the interaction between human Sirpα and human CD47.
摘要:
A compound for use in a method for treating cancer cells or tumours that are CD47+, the compound comprising a polypeptide capable of modulating the interaction between human Sirpα and human CD47.